ERK signalling: a master regulator of cell behaviour, life and fate

H Lavoie, J Gagnon, M Therrien - Nature reviews Molecular cell biology, 2020 - nature.com
The proteins extracellular signal-regulated kinase 1 (ERK1) and ERK2 are the downstream
components of a phosphorelay pathway that conveys growth and mitogenic signals largely …

Coordinating gene expression during the cell cycle

M Fischer, AE Schade, TB Branigan, GA Müller… - Trends in biochemical …, 2022 - cell.com
Cell cycle-dependent gene transcription is tightly controlled by the retinoblastoma (RB): E2F
and DREAM complexes, which repress all cell cycle genes during quiescence. Cyclin …

CDK4 and CDK6 kinases: From basic science to cancer therapy

A Fassl, Y Geng, P Sicinski - Science, 2022 - science.org
BACKGROUND Cyclins and cyclin-dependent kinases (CDKs) drive cell division. Of
particular importance to the cancer field are D-cyclins, which activate CDK4 and CDK6. In …

Mitogen signaling strength and duration can control cell cycle decisions

R Nussinov, W Zhang, Y Liu, H Jang - Science Advances, 2024 - science.org
Decades ago, mitogen-promoted signaling duration and strength were observed to be
sensed by the cell and to be critical for its decisions: to proliferate or differentiate. Landmark …

Neurogenesis in the embryonic and adult brain: same regulators, different roles

N Urbán, F Guillemot - Frontiers in cellular neuroscience, 2014 - frontiersin.org
Neurogenesis persists in adult mammals in specific brain areas, known as neurogenic
niches. Adult neurogenesis is highly dynamic and is modulated by multiple physiological …

Long noncoding RNAs: past, present, and future

JTY Kung, D Colognori, JT Lee - Genetics, 2013 - academic.oup.com
Long noncoding RNAs (lncRNAs) have gained widespread attention in recent years as a
potentially new and crucial layer of biological regulation. lncRNAs of all kinds have been …

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)

C Sánchez-Martínez, MJ Lallena… - Bioorganic & medicinal …, 2019 - Elsevier
Sustained proliferative capacity and gene dysregulation are hallmarks of cancer. In
mammalian cells, cyclin-dependent kinases (CDKs) control critical cell cycle checkpoints …

Targeting cell cycle in breast cancer: CDK4/6 inhibitors

M Piezzo, S Cocco, R Caputo, D Cianniello… - International journal of …, 2020 - mdpi.com
Deregulation of cell cycle, via cyclin D/CDK/pRb pathway, is frequently observed in breast
cancer lending support to the development of drugs targeting the cell cycle control …

Signaling pathways that control cell proliferation

RJ Duronio, Y Xiong - Cold Spring Harbor perspectives …, 2013 - cshperspectives.cshlp.org
Cells decide to proliferate or remain quiescent using signaling pathways that link information
about the cellular environment to the G1 phase of the cell cycle. Progression through G1 …

Defining the human copper proteome and analysis of its expression variation in cancers

S Blockhuys, E Celauro, C Hildesjö, A Feizi, O Stål… - Metallomics, 2017 - academic.oup.com
Copper (Cu) is essential for living organisms, and acts as a cofactor in many metabolic
enzymes. To avoid the toxicity of free Cu, organisms have specific transport systems that …